GENPREX INC (GNPX) Fundamental Analysis & Valuation

NASDAQ:GNPX • US3724463027

Current stock price

1.02 USD
0 (0%)
At close:
1 USD
-0.02 (-1.96%)
After Hours:

This GNPX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GNPX Profitability Analysis

1.1 Basic Checks

  • In the past year GNPX has reported negative net income.
  • GNPX had a negative operating cash flow in the past year.
  • GNPX had negative earnings in each of the past 5 years.
  • In the past 5 years GNPX always reported negative operating cash flow.
GNPX Yearly Net Income VS EBIT VS OCF VS FCFGNPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • GNPX has a worse Return On Assets (-458.87%) than 94.57% of its industry peers.
  • GNPX has a Return On Equity of -1262.44%. This is amonst the worse of the industry: GNPX underperforms 82.17% of its industry peers.
Industry RankSector Rank
ROA -458.87%
ROE -1262.44%
ROIC N/A
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
GNPX Yearly ROA, ROE, ROICGNPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GNPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GNPX Yearly Profit, Operating, Gross MarginsGNPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GNPX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, GNPX has more shares outstanding
  • GNPX has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for GNPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GNPX Yearly Shares OutstandingGNPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M
GNPX Yearly Total Debt VS Total AssetsGNPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • GNPX has an Altman-Z score of -72.55. This is a bad value and indicates that GNPX is not financially healthy and even has some risk of bankruptcy.
  • GNPX's Altman-Z score of -72.55 is on the low side compared to the rest of the industry. GNPX is outperformed by 93.99% of its industry peers.
  • There is no outstanding debt for GNPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -72.55
ROIC/WACCN/A
WACCN/A
GNPX Yearly LT Debt VS Equity VS FCFGNPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • GNPX has a Current Ratio of 0.84. This is a bad value and indicates that GNPX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GNPX's Current ratio of 0.84 is on the low side compared to the rest of the industry. GNPX is outperformed by 87.98% of its industry peers.
  • GNPX has a Quick Ratio of 0.84. This is a bad value and indicates that GNPX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GNPX's Quick ratio of 0.84 is on the low side compared to the rest of the industry. GNPX is outperformed by 87.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
GNPX Yearly Current Assets VS Current LiabilitesGNPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GNPX Growth Analysis

3.1 Past

  • GNPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.15%, which is quite impressive.
EPS 1Y (TTM)60.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, GNPX will show a very strong growth in Earnings Per Share. The EPS will grow by 41.33% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNPX Yearly Revenue VS EstimatesGNPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 50M 100M 150M
GNPX Yearly EPS VS EstimatesGNPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 -500 -1K -1.5K

More info and screens

Find the best growth stocksShow best growing peers

1

4. GNPX Valuation Analysis

4.1 Price/Earnings Ratio

  • GNPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNPX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNPX Price Earnings VS Forward Price EarningsGNPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNPX Per share dataGNPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300 -400

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GNPX's earnings are expected to grow with 41.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.33%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GNPX Dividend Analysis

5.1 Amount

  • No dividends for GNPX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GNPX Fundamentals: All Metrics, Ratios and Statistics

GENPREX INC

NASDAQ:GNPX (4/24/2026, 8:00:01 PM)

After market: 1 -0.02 (-1.96%)

1.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-30
Earnings (Next)05-11
Inst Owners0.23%
Inst Owner Change647.58%
Ins Owners0.85%
Ins Owner Change5.82%
Market Cap9.22M
Revenue(TTM)N/A
Net Income(TTM)-17.56M
Analysts82.86
Price TargetN/A
Short Float %4.32%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.63
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-453.5
EYN/A
EPS(NY)-1.17
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.56
OCFYN/A
SpS0
BVpS0.15
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -458.87%
ROE -1262.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -72.55
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)236.4%
Cap/Depr(5y)318.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.36%
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.59%
OCF growth 3YN/A
OCF growth 5YN/A

GENPREX INC / GNPX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GENPREX INC (GNPX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GNPX.


Can you provide the valuation status for GENPREX INC?

ChartMill assigns a valuation rating of 1 / 10 to GENPREX INC (GNPX). This can be considered as Overvalued.


Can you provide the profitability details for GENPREX INC?

GENPREX INC (GNPX) has a profitability rating of 0 / 10.